仁度生物
(688193)
| 流通市值：20.70亿 | | | 总市值：20.70亿 |
| 流通股本：4006.99万 | | | 总股本：4006.99万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 148,204,783.71 | 228,877,618.7 | 328,927,414.04 | 261,582,058.68 |
| 交易性金融资产 | 635,258,041.1 | 542,822,630.14 | 442,709,777.78 | 510,959,655.56 |
| 应收票据及应收账款 | 47,083,351.69 | 48,312,014.88 | 47,001,938.59 | 49,371,105.29 |
| 应收账款 | 47,083,351.69 | 48,312,014.88 | 47,001,938.59 | 49,371,105.29 |
| 应收款项融资 | 276,865.46 | 675,747.14 | 638,993.54 | - |
| 预付款项 | 4,415,063.51 | 4,572,760.42 | 4,536,204.44 | 5,858,195.71 |
| 其他应收款合计 | 1,730,878.2 | 1,118,924.11 | 1,246,492.25 | 511,462.55 |
| 存货 | 24,081,813.11 | 24,071,125.75 | 24,509,308.32 | 25,137,015.39 |
| 其他流动资产 | 30,215,537.37 | 30,213,982.54 | 30,141,084.62 | 31,324,883.63 |
| 流动资产合计 | 891,266,334.15 | 880,664,803.68 | 879,711,213.58 | 884,744,376.81 |
| 非流动资产: | | | | |
| 固定资产 | 68,738,438.32 | 71,735,645.1 | 74,659,220.6 | 77,670,995.92 |
| 在建工程 | 333,185.57 | 57,075.48 | - | 409,541.28 |
| 使用权资产 | 3,756,907.2 | 4,396,688.32 | 3,902,789.17 | 4,142,089.06 |
| 无形资产 | 303,018.07 | 298,508.82 | 352,303.3 | 409,619.71 |
| 长期待摊费用 | 5,864,660.32 | 6,266,690.31 | 7,095,327.7 | 6,739,431.96 |
| 递延所得税资产 | 19,914,087.14 | 21,515,848.58 | 20,908,538.18 | 20,242,265.91 |
| 非流动资产合计 | 98,910,296.62 | 104,270,456.61 | 106,918,178.95 | 109,613,943.84 |
| 资产总计 | 990,176,630.77 | 984,935,260.29 | 986,629,392.53 | 994,358,320.65 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 2,028,025 | 2,496,659.22 | 4,608,695.97 | 3,037,835.97 |
| 应付账款 | 2,028,025 | 2,496,659.22 | 4,608,695.97 | 3,037,835.97 |
| 合同负债 | 3,984,855.65 | 3,659,138.03 | 4,885,698.08 | 9,012,761.97 |
| 应付职工薪酬 | 8,411,816.84 | 7,672,394.23 | 7,471,116.26 | 11,827,641.91 |
| 应交税费 | 2,821,986.05 | 2,885,707.74 | 2,365,982.59 | 742,833.38 |
| 其他应付款合计 | 45,413,302.16 | 47,691,154.66 | 44,740,897.03 | 47,777,766.98 |
| 一年内到期的非流动负债 | 1,220,172.35 | 1,010,865.38 | 1,129,295.79 | 1,908,493.38 |
| 其他流动负债 | 343,180.51 | 332,226.66 | 93,254.9 | 107,835.49 |
| 流动负债合计 | 64,223,338.56 | 65,748,145.92 | 65,294,940.62 | 74,415,169.08 |
| 非流动负债: | | | | |
| 租赁负债 | 3,134,268.23 | 3,516,982.69 | 2,890,172.26 | 2,327,989.12 |
| 预计负债 | 12,677.82 | 18,693.9 | 57,083.13 | 12,111.44 |
| 递延收益 | 4,450,107.66 | 5,004,404.97 | 4,962,722.57 | 5,723,677.98 |
| 非流动负债合计 | 7,597,053.71 | 8,540,081.56 | 7,909,977.96 | 8,063,778.54 |
| 负债合计 | 71,820,392.27 | 74,288,227.48 | 73,204,918.58 | 82,478,947.62 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 40,069,870 | 40,000,000 | 40,000,000 | 40,000,000 |
| 资本公积 | 781,133,366.38 | 778,197,538.26 | 777,818,952.15 | 777,440,366.02 |
| 减:库存股 | 35,659,786.74 | 35,659,786.74 | 35,659,786.74 | 35,659,786.74 |
| 其他综合收益 | -196,701.65 | 75,546.37 | 177,751.26 | 232,167.61 |
| 盈余公积 | 14,035,318.24 | 14,035,318.24 | 14,035,318.24 | 14,035,318.24 |
| 未分配利润 | 118,974,172.27 | 113,998,416.68 | 117,052,239.04 | 115,831,307.9 |
| 归属于母公司股东权益合计 | 918,356,238.5 | 910,647,032.81 | 913,424,473.95 | 911,879,373.03 |
| 股东权益合计 | 918,356,238.5 | 910,647,032.81 | 913,424,473.95 | 911,879,373.03 |
| 负债和股东权益合计 | 990,176,630.77 | 984,935,260.29 | 986,629,392.53 | 994,358,320.65 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |